Innovative Partnership to Develop New Therapies for Neutrophil-Driven Inflammatory Conditions A groundbreaking collaboration involves Evogene, Systasy, and LMU University Hospital Munich to create new therapies targeting neutrophil-related inflammatory diseases.

Innovative Partnership to Develop New Therapies for Neutrophil-Driven Inflammatory Conditions #Germany #Munich #Evogene #Systasy #LMU_Hospital